[
  {
    "date": "2023-12-30",
    "symbol": "BEAM",
    "period": "FY",
    "netincomeloss": -132527000,
    "trdarrsecuritiesaggavailamt": 147603,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "BEAM",
    "entityregistrantname": "Beam Therapeutics Inc.",
    "entitycentralindexkey": 1745999,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large Accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "documentfinstmterrorcorrectionflag": "false",
    "entitysmallbusiness": "false",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityshellcompany": "false",
    "security12btitle": "Common Stock, par value $0.01 per share",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-39208",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "81-5238376",
    "entityaddressaddressline1": "238 Main Street",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2142,
    "cityareacode": 857,
    "localphonenumber": "327-8775",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "Deloitte & Touche LLP",
    "auditorfirmid": 34,
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 435895000,
    "availableforsaledebtsecuritiesandequitysecuritiesfvnicurrent": 753981000,
    "prepaidexpenseandotherassetscurrent": 21167000,
    "assetscurrent": 1211043000,
    "propertyplantandequipmentnet": 124960000,
    "restrictedcashnoncurrent": 8719000,
    "operatingleaserightofuseasset": 112846000,
    "otherassetsnoncurrent": 2146000,
    "assets": 1459714000,
    "accountspayablecurrent": 1617000,
    "accruedexpensesandothercurrentliabilities": 111664000,
    "derivativeliabilitiescurrent": 10800000,
    "contractwithcustomerliabilitycurrent": 68706000,
    "operatingleaseliabilitycurrent": 12778000,
    "liabilitiescurrent": 205565000,
    "operatingleaseliabilitynoncurrent": 159911000,
    "businesscombinationcontingentconsiderationliabilitynoncurrent": 2723000,
    "contractwithcustomerliabilitynoncurrent": 109888000,
    "otherliabilitiesnoncurrent": 298000,
    "liabilities": 478385000,
    "commonstockvalue": 816000,
    "additionalpaidincapital": 2169798000,
    "accumulatedothercomprehensiveincomelossnetoftax": 604000,
    "retainedearningsaccumulateddeficit": -1189889000,
    "stockholdersequity": 981329000,
    "liabilitiesandstockholdersequity": 1459714000,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": 25000000,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 250000000,
    "commonstocksharesissued": 81632496,
    "commonstocksharesoutstanding": 81632496,
    "revenuefromcontractwithcustomerexcludingassessedtax": 377709000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2023#LicenseMember",
    "researchanddevelopmentexpense": 437381000,
    "generalandadministrativeexpense": 116813000,
    "operatingexpenses": 554194000,
    "operatingincomeloss": -176485000,
    "derivativegainlossonderivativenet": 7500000,
    "equitysecuritiesfvnigainloss": -18592000,
    "changeinfairvalueofcontingentconsiderationliabilities": -9740000,
    "interestandotherincomeexpensenet": 46676000,
    "nonoperatingincomeexpense": 45324000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -131161000,
    "incometaxexpensebenefit": 1366000,
    "othercomprehensiveincomeavailableforsalesecuritiesadjustmentnetoftaxportionattributabletoparent": 3034000,
    "comprehensiveincomenetoftax": -129493000,
    "earningspersharebasic": -1.72,
    "earningspersharediluted": -1.72,
    "weightedaveragenumberofsharesoutstandingbasic": 77151771,
    "weightedaveragenumberofdilutedsharesoutstanding": 77151771,
    "sharesoutstanding": 81632496,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 1000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 130403,
    "stockissuedduringperiodvaluenewissues": 70000,
    "stockissuedduringperiodsharesnewissues": 6952703,
    "issuanceofunregisteredcommonsharesinconnectionwithlicenseagreement1": 20000,
    "issuanceofunregisteredcommonsharesinconnectionwithlicenseagreement": 2004811,
    "stockissuedduringperiodvaluerestrictedstockawardgross": 5000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 469531,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 98647000,
    "stockissuedduringperiodvaluestockoptionsexercised": 8000,
    "stockissuedduringperiodsharesstockoptionsexercised": 797709,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": 3034000,
    "stockissuancecosts": 6100000,
    "profitloss": -132527000,
    "depreciationdepletionandamortization": 20012000,
    "investmentincomenetamortizationofdiscountandpremium": 29743000,
    "sharebasedcompensation": 98647000,
    "changeinoperatingleaserightofuseassets": 9519000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 6473000,
    "increasedecreaseinaccountspayable": -7578000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 67663000,
    "increasedecreaseinoperatingleaseliability": -10168000,
    "increasedecreaseincollaborationreceivable": 146000,
    "increasedecreaseincontractwithcustomerliability": -159559000,
    "increasedecreaseinothernoncurrentliabilities": -194000,
    "netcashprovidedbyusedinoperatingactivities": -149195000,
    "paymentstoacquirepropertyplantandequipment": 33732000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 984338000,
    "proceedsfrommaturitiesprepaymentsandcallsofavailableforsalesecurities": 1089910000,
    "netcashprovidedbyusedininvestingactivities": 71840000,
    "proceedsfromissuanceofcommonstock": 236568000,
    "proceedsfromstockplans": 3032000,
    "paymentsofstockissuancecosts": 631000,
    "financeleaseprincipalpayments": 2252000,
    "proceedsfromstockoptionsexercised": 6131000,
    "proceedsfromissuanceofprivateplacement": 33600000,
    "netcashprovidedbyusedinfinancingactivities": 276448000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 199093000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 444614000,
    "interestpaidnet": 160000,
    "capitalexpendituresincurredbutnotyetpaid": 1403000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 3852000,
    "stocksoldduringperiodsharesnewissues": 2908009,
    "sharesissuedpricepershare": 103.16,
    "grossproceedsfromissuanceofcommonstock": 300000000,
    "cashcashequivalentsandshortterminvestments": 1200000000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentusefullifedescriptionoftermextensibleenumeration": "http://fasb.org/us-gaap/2023#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember",
    "contractwithcustomerliability": 178594000,
    "contractwithcustomerliabilityrevenuerecognized": 159559000,
    "propertyplantandequipmentgross": 100186000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 50182000,
    "depreciation": 20012000,
    "cashandcashequivalentsfairvaluedisclosure": 435689000,
    "availableforsalesecuritiesdebtsecurities": 285289000,
    "equitysecuritiesfvni": 21875000,
    "assetsfairvaluedisclosure": 1189670000,
    "derivativefairvalueofderivativeliability": 5200000,
    "businesscombinationcontingentconsiderationliability": 1371000,
    "liabilitiesfairvaluedisclosure": 13523000,
    "equitysharesheld": 546970,
    "derivativeliabilitymeasurementinput": 27.22,
    "derivativetermofcontract": "P0Y21D",
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 5200000,
    "liabilitiesfairvalueadjustment": -3800000,
    "businesscombinationcontingentconsiderationliabilitymeasurementinput": 0.1,
    "businesscombinationcontingentconsiderationliabilityexpectedachievementyear": 2025,
    "availableforsaledebtsecuritiesamortizedcostbasis": 285054000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 250000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 15000,
    "equitysecuritiesfvnicost": 21875000,
    "availableforsaledebtsecuritiesandequitysecuritiesfvniamortizedcostbasis": 753377000,
    "availableforsaledebtsecuritiesandequitysecuritiesfvniaccumulatedgrossunrealizedgainbeforetaxes": 1077000,
    "availableforsaledebtsecuritiesandequitysecuritiesfvniaccumulatedgrossunrealizedlossbeforetaxes": 473000,
    "availableforsaledebtsecuritiesandequitysecuritiesfvni": 753981000,
    "debtsecuritiesavailableforsalematurityperiod": "less than one year",
    "accruedcontingentobligationcurrent": 43280000,
    "employeerelatedliabilitiescurrent": 21774000,
    "accruedresearchcosts": 9804000,
    "accruedprocessdevelopmentandmanufacturingcosts": 4697000,
    "accruedprofessionalfeescurrent": 3468000,
    "accruedequipmentfinancingcostscurrent": 484000,
    "otheraccruedliabilitiescurrent": 28157000,
    "accruedliabilitiesandotherliabilities": 111664000,
    "losscontingencyaccrualatcarryingvalue": 21300000,
    "operatingleaseliability": 172689000,
    "operatingleasecost": 22063000,
    "variableleasecost": 5777000,
    "shorttermleasecost": 9000000,
    "leasecost": 36840000,
    "operatingleaseweightedaverageremainingleaseterm1": "P10Y3M18D",
    "operatingleaseweightedaveragediscountratepercent": 0.076,
    "operatingleasepayments": 22603000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 24985000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 25315000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 22526000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 23157000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 22806000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 132500000,
    "lesseeoperatingleaseliabilitypaymentsdue": 251289000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 78600000,
    "restructuringcharges": 6700000,
    "restructuringreserve": 4495000,
    "paymentsforrestructuring": 1999000,
    "contingentobligationandnonroyaltysublicensefees": 43500000,
    "accruedliabilitiescurrentandnoncurrent": 43300000,
    "successpayments": 5000000,
    "successpaymentsvaluationmultiples": 5,
    "aggregatemilestoneamount": 75900000,
    "collaborationagreementperformanceobligationrevenuerecognized": 216400000,
    "equitysharesvalueheld": 14200000,
    "commonstockvotingrights": "The holders of the Company’s common stock are entitled to one vote for each share of common stock.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P2Y",
    "commonstockcapitalsharesreservedforfutureissuance": 12376374,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1173189,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 130403,
    "sharebasedcompensationarrangementbysharebasedpaymentawardannualincreasepercentage": 0.04,
    "allocatedsharebasedcompensationexpense": 57812000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 27.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 20000000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 7.69,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 111500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 13800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 72800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.763,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.788,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0373,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 8276033,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2356838,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 831488,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4818116,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 42.59,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 39.62,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 60.18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 37.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 51653000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 45895000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 2927152,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 2050025,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 469531,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 346161,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 40.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 28.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 67.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 52.49,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2927152,
    "netincomelossavailabletocommonstockholdersbasic": -132527000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.133,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.18,
    "effectiveincometaxratereconciliationnondeductibleexpense": 0.025,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.509,
    "effectiveincometaxratecontinuingoperations": -0.011,
    "deferredtaxassetsoperatinglosscarryforwards": 3959000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 56759000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 17386000,
    "deferredtaxassetsdeferredincome": 48792000,
    "deferredtaxassetsderivativeinstruments": 2951000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 20587000,
    "deferredtaxassetsamortization": 30917000,
    "deferredtaxassetscapitalizedresearch": 137721000,
    "deferredtaxassetsleasingarrangements": 47179000,
    "deferredtaxassetsgross": 366251000,
    "deferredtaxliabilitiesleasingarrangements": 30830000,
    "deferredtaxliabilitiespropertyplantandequipment": 649000,
    "deferredtaxliabilitiesother": 5415000,
    "deferredtaxassetsvaluationallowance": 329357000,
    "valuationallowancedeferredtaxassetchangeinamount": 75000000,
    "currentincometaxexpensebenefit": 1400000,
    "operatinglosscarryforwards": 16600000,
    "taxcreditcarryforwardamount": 41300000,
    "taxcreditsexpirationstartingyear": 2042,
    "opentaxyear": 2020,
    "relatedpartytransactionamountsoftransaction": 400000,
    "numberoffoundershareholders": 3,
    "definedcontributionplanname": "401(k)",
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.5,
    "definedcontributionplanemployermatchingcontributionpercent": 0.06,
    "definedcontributionplanemployerdiscretionarycontributionamount": 2500000
  },
  {
    "date": "2022-12-30",
    "symbol": "BEAM",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "BEAM",
    "entityregistrantname": "Beam Therapeutics Inc.",
    "entitycentralindexkey": 1745999,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large Accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entitysmallbusiness": "false",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityshellcompany": "false",
    "security12btitle": "Common Stock, par value $0.01 per share",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-39208",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "81-5238376",
    "entityaddressaddressline1": "238 Main Street",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2142,
    "cityareacode": 857,
    "localphonenumber": "327-8775",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "Deloitte & Touche LLP",
    "auditorfirmid": 34,
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 232767000,
    "availableforsaledebtsecuritiesandequitysecuritiesfvnicurrent": 845367000,
    "prepaidexpenseandotherassetscurrent": 14762000,
    "assetscurrent": 1092896000,
    "propertyplantandequipmentnet": 115620000,
    "restrictedcashnoncurrent": 12754000,
    "operatingleaserightofuseasset": 118513000,
    "otherassetsnoncurrent": 1931000,
    "assets": 1341714000,
    "accountspayablecurrent": 9029000,
    "accruedexpensesandothercurrentliabilities": 48059000,
    "derivativeliabilitiescurrent": 18300000,
    "contractwithcustomerliabilitycurrent": 135974000,
    "operatingleaseliabilitycurrent": 10380000,
    "financeleaseliabilitycurrent": 1853000,
    "liabilitiescurrent": 223595000,
    "operatingleaseliabilitynoncurrent": 168625000,
    "financeleaseliabilitynoncurrent": 1154000,
    "businesscombinationcontingentconsiderationliabilitynoncurrent": 12463000,
    "contractwithcustomerliabilitynoncurrent": 202179000,
    "otherliabilitiesnoncurrent": 224000,
    "liabilities": 608240000,
    "commonstockvalue": 712000,
    "additionalpaidincapital": 1792554000,
    "accumulatedothercomprehensiveincomelossnetoftax": -2430000,
    "retainedearningsaccumulateddeficit": -1057362000,
    "stockholdersequity": 733474000,
    "liabilitiesandstockholdersequity": 1341714000,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": 25000000,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 250000000,
    "commonstocksharesissued": 71277339,
    "commonstocksharesoutstanding": 71277339,
    "revenuefromcontractwithcustomerexcludingassessedtax": 60920000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2022#LicenseMember",
    "researchanddevelopmentexpense": 311594000,
    "generalandadministrativeexpense": 87805000,
    "operatingexpenses": 399399000,
    "operatingincomeloss": -338479000,
    "derivativegainlossonderivativenet": 23900000,
    "equitysecuritiesfvnigainloss": 20200000,
    "changeinfairvalueofcontingentconsiderationliabilities": -18904000,
    "interestandotherincomeexpensenet": 15297000,
    "nonoperatingincomeexpense": 78301000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -260178000,
    "incometaxexpensebenefit": 3410000,
    "incomelossfromequitymethodinvestments": -25500000,
    "netincomeloss": -289088000,
    "othercomprehensiveincomeavailableforsalesecuritiesadjustmentnetoftaxportionattributabletoparent": -2380000,
    "comprehensiveincomenetoftax": -291468000,
    "netincomelossavailabletocommonstockholdersbasic": -289088000,
    "earningspersharebasic": -4.13,
    "earningspersharediluted": -4.13,
    "weightedaveragenumberofsharesoutstandingbasic": 70015305,
    "weightedaveragenumberofdilutedsharesoutstanding": 70015305,
    "sharesoutstanding": 71277339,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 3075000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 70073,
    "stockissuedduringperiodvaluenewissues": 19000,
    "stockissuedduringperiodsharesnewissues": 1909103,
    "stockissuedduringperiodvaluerestrictedstockawardgross": 4000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 424303,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 84321000,
    "stockissuedduringperiodvaluestockoptionsexercised": 5000,
    "stockissuedduringperiodsharesstockoptionsexercised": 484435,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": -2380000,
    "stockissuancecosts": 2700000,
    "profitloss": -289088000,
    "depreciationdepletionandamortization": 14147000,
    "investmentincomenetamortizationofdiscountandpremium": 9410000,
    "sharebasedcompensation": 84321000,
    "changeinoperatingleaserightofuseassets": 8430000,
    "changeinfairvalueofderivativeliabilities": -23900000,
    "othernoncashincomeexpense": -3000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 7753000,
    "increasedecreaseinaccountspayable": 2373000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -16933000,
    "increasedecreaseinoperatingleaseliability": 12430000,
    "increasedecreaseincollaborationreceivable": -300000000,
    "increasedecreaseincontractwithcustomerliability": -35920000,
    "increasedecreaseinothernoncurrentliabilities": -2569000,
    "netcashprovidedbyusedinoperatingactivities": 22527000,
    "paymentstoacquirepropertyplantandequipment": 48951000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 1616999000,
    "proceedsfrommaturitiesprepaymentsandcallsofavailableforsalesecurities": 1204614000,
    "netcashprovidedbyusedininvestingactivities": -461336000,
    "proceedsfromissuanceofcommonstock": 108258000,
    "proceedsfromstockplans": 3075000,
    "paymentsofstockissuancecosts": 188000,
    "financeleaseprincipalpayments": 2287000,
    "proceedsfromstockoptionsexercised": 2732000,
    "netcashprovidedbyusedinfinancingactivities": 111590000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -327219000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 245521000,
    "interestpaidnet": 376000,
    "capitalexpendituresincurredbutnotyetpaid": 5783000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 41050000,
    "contributionofproperty": 25500000,
    "sharesissuedpricepershare": 82.38,
    "cashcashequivalentsandshortterminvestments": 1100000000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentestimatedusefullives": "Shorter of useful life or remaining term",
    "propertyplantandequipmentgross": 85804000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 30170000,
    "depreciation": 14097000,
    "cashandcashequivalentsfairvaluedisclosure": 218794000,
    "availableforsalesecuritiesdebtsecurities": 577728000,
    "equitysecuritiesfvni": 40467000,
    "assetsfairvaluedisclosure": 1078134000,
    "derivativefairvalueofderivativeliability": 9000000,
    "businesscombinationcontingentconsiderationliability": 6025000,
    "liabilitiesfairvaluedisclosure": 30763000,
    "equitysharesheld": 546970,
    "derivativeliabilitymeasurementinput": 39.11,
    "derivativetermofcontract": "P0Y29D",
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 9000000,
    "liabilitiesfairvalueadjustment": -12000000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityperiodincreasedecrease": -18334000,
    "businesscombinationcontingentconsiderationliabilitymeasurementinput": 0.1,
    "businesscombinationcontingentconsiderationliabilityexpectedachievementyear": 2024,
    "availableforsaledebtsecuritiesamortizedcostbasis": 578813000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 72000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1157000,
    "equitysecuritiesfvnicost": 40467000,
    "availableforsaledebtsecuritiesandequitysecuritiesfvniamortizedcostbasis": 847797000,
    "availableforsaledebtsecuritiesandequitysecuritiesfvniaccumulatedgrossunrealizedgainbeforetaxes": 85000,
    "availableforsaledebtsecuritiesandequitysecuritiesfvniaccumulatedgrossunrealizedlossbeforetaxes": 2515000,
    "availableforsaledebtsecuritiesandequitysecuritiesfvni": 845367000,
    "debtsecuritiesavailableforsalematurityperiod": "less than one year",
    "employeerelatedliabilitiescurrent": 19122000,
    "accruedprofessionalfeescurrent": 6751000,
    "accruedprocessdevelopmentandmanufacturingcosts": 5080000,
    "accruedresearchcosts": 4844000,
    "otheraccruedliabilitiescurrent": 12262000,
    "accruedliabilitiescurrent": 3400000,
    "operatingleaserentpaymentsbeginmonthandyear": "2022-12",
    "operatingleaseliability": 14000000,
    "securitydeposit": 9700000,
    "lesseeoperatingleasetermofcontract": "P15Y",
    "operatingleasecost": 19536000,
    "variableleasecost": 4364000,
    "shorttermleasecost": 307000,
    "subleaseincome": 1319000,
    "leasecost": 22888000,
    "operatingleaseweightedaverageremainingleaseterm1": "P11Y",
    "operatingleaseweightedaveragediscountratepercent": 0.075,
    "operatingleasepayments": 19052000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 21576000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 24452000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 25036000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 22221000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 22845000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 151828000,
    "lesseeoperatingleaseliabilitypaymentsdue": 267958000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 88953000,
    "financeleaseliabilitypaymentsduenexttwelvemonths": 2013000,
    "financeleaseliabilitypaymentsdueyeartwo": 511000,
    "financeleaseliabilitypaymentsdue": 2524000,
    "financeleaseliabilityundiscountedexcessamount": 192000,
    "directfinancingleaseresidualvalueofleasedasset": 675000,
    "financeleaseliability": 3007000,
    "financeleaseliabilitypaymentsinterestpercentage": 0.0876,
    "financeleaseinterestexpense": 376000,
    "equitymethodinvestmentownershippercentage": 0.315,
    "licenseandcollaborationagreementoutstandingcommonstockheldpercentage": 0.958,
    "equitymethodinvestmentquotedmarketvalue": 25500000,
    "alternativeinvestmentmeasurementinput": 0.68,
    "nonroyaltysublicensefeesowed": 2700000,
    "successpayments": 5000000,
    "successpaymentsvaluationmultiples": 5,
    "aggregatemilestoneamount": 75900000,
    "milestoneexpense": 200000,
    "nonroyaltysublicensefeespaid": 6100000,
    "collaborationarrangementinitialterm": "P3Y",
    "collaborationarrangementextensiontermdescription": "which may be extended for up to two successive one-year periods",
    "collaborationagreementperformanceobligationrevenueperiodforrecognition": "P3Y",
    "collaborationagreementperformanceobligationrevenuerecognized": 2100000,
    "collaborationagreementaggregatetransactionprice": 25500000,
    "contractwithcustomerliability": 400000,
    "collaborativearrangementrightsandobligations": "The Company had an obligation to issue $5.0 million in shares of its common stock to Prime Medicine, and Prime Medicine had an obligation to issue 5,000,000 shares of its common stock to the Company, should the Company elect to extend the collaboration beyond one year",
    "commonstockvotingrights": "The holders of the Company’s common stock are entitled to one vote for each share of common stock.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P2Y",
    "commonstockcapitalsharesreservedforfutureissuance": 10797126,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1555915,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 70073,
    "sharebasedcompensationarrangementbysharebasedpaymentawardannualincreasepercentage": 0.04,
    "allocatedsharebasedcompensationexpense": 52004000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 40.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 23400000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 5.64,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 135300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 53100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 92600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.748,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.773,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0227,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7548392,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2215246,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 216611,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3790249,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 41.77,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 60.75,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 55.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 27.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 110990000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 87547000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1692819,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1071925,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 424303,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 81009,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 65.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 51.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 53.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 71.02,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1692819,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.074,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.042,
    "effectiveincometaxratereconciliationnondeductibleexpense": 0.018,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.32,
    "effectiveincometaxratecontinuingoperations": -0.012,
    "deferredtaxassetsoperatinglosscarryforwards": 25740000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 27801000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 12472000,
    "deferredtaxassetsdeferredincome": 84622000,
    "deferredtaxassetsderivativeinstruments": 4920000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 9714000,
    "deferredtaxassetsamortization": 19893000,
    "deferredtaxassetscapitalizedresearch": 63816000,
    "deferredtaxassetsleasingarrangements": 48122000,
    "deferredtaxassetsgross": 297100000,
    "deferredtaxliabilitiesleasingarrangements": 31860000,
    "deferredtaxliabilitiespropertyplantandequipment": 508000,
    "deferredtaxliabilitiesother": 10325000,
    "deferredtaxassetsvaluationallowance": 254407000,
    "capitalizedrdcosts": 237400000,
    "valuationallowancedeferredtaxassetchangeinamount": 82300000,
    "operatinglosscarryforwards": 120300000,
    "amortizationofrdtaxterm": "P5Y",
    "taxcreditcarryforwardamount": 18900000,
    "taxcreditsexpirationstartingyear": 2042,
    "opentaxyear": 2018,
    "relatedpartytransactionamountsoftransaction": 400000,
    "numberoffoundershareholders": 3,
    "relatedpartytransactionpurchasesfromrelatedparty": 400000,
    "relatedpartytransactionotherrevenuesfromtransactionswithrelatedparty": 29800000,
    "definedcontributionplanname": "401(k)",
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.5,
    "definedcontributionplanemployermatchingcontributionpercent": 0.06,
    "definedcontributionplanemployerdiscretionarycontributionamount": 2000000
  },
  {
    "date": "2021-12-30",
    "symbol": "BEAM",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "BEAM",
    "entityregistrantname": "Beam Therapeutics Inc.",
    "entitycentralindexkey": 1745999,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large Accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entitysmallbusiness": "false",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityshellcompany": "false",
    "security12btitle": "Common Stock, par value $0.01 per share",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-39208",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "81-5238376",
    "entityaddressaddressline1": "238 Main Street",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2142,
    "cityareacode": 857,
    "localphonenumber": "327-8775",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "Deloitte & Touche LLP",
    "auditorfirmid": 34,
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 559994000,
    "availableforsaledebtsecuritiesandequitysecuritiesfvnicurrent": 405653000,
    "collaborationreceivablecurrent": 300000000,
    "prepaidexpenseandotherassetscurrent": 7360000,
    "assetscurrent": 1273007000,
    "propertyplantandequipmentnet": 84258000,
    "restrictedcashnoncurrent": 12746000,
    "operatingleaserightofuseasset": 102718000,
    "otherassetsnoncurrent": 1724000,
    "assets": 1474453000,
    "accountspayablecurrent": 7474000,
    "accruedexpensesandothercurrentliabilities": 28921000,
    "accruedsublicensefeescurrent": 38743000,
    "derivativeliabilitiescurrent": 42200000,
    "contractwithcustomerliabilitycurrent": 86270000,
    "operatingleaseliabilitycurrent": 7540000,
    "financeleaseliabilitycurrent": 2287000,
    "liabilitiescurrent": 213435000,
    "operatingleaseliabilitynoncurrent": 134810000,
    "financeleaseliabilitynoncurrent": 3007000,
    "businesscombinationcontingentconsiderationliabilitynoncurrent": 31367000,
    "contractwithcustomerliabilitynoncurrent": 262303000,
    "otherliabilitiesnoncurrent": 2793000,
    "liabilities": 647715000,
    "commonstockvalue": 684000,
    "additionalpaidincapital": 1594378000,
    "accumulatedothercomprehensiveincomelossnetoftax": -50000,
    "retainedearningsaccumulateddeficit": -768274000,
    "stockholdersequity": 826738000,
    "liabilitiesandstockholdersequity": 1474453000,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": 25000000,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 250000000,
    "commonstocksharesissued": 68581251,
    "commonstocksharesoutstanding": 68389425,
    "revenuefromcontractwithcustomerexcludingassessedtax": 51844000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2021-01-31#LicenseMember",
    "researchanddevelopmentexpense": 387087000,
    "generalandadministrativeexpense": 57222000,
    "operatingexpenses": 444309000,
    "operatingincomeloss": -392465000,
    "derivativegainlossonderivativenet": -1000000,
    "equitysecuritiesfvnigainloss": 17690000,
    "changeinfairvalueofcontingentconsiderationliabilities": -5146000,
    "interestandotherincomeexpensenet": -9000,
    "nonoperatingincomeexpense": 21827000,
    "netincomeloss": -370638000,
    "othercomprehensiveincomeavailableforsalesecuritiesadjustmentnetoftaxportionattributabletoparent": -41000,
    "comprehensiveincomenetoftax": -370679000,
    "netincomelossavailabletocommonstockholdersbasic": -370638000,
    "earningspersharebasic": -5.77,
    "earningspersharediluted": -5.77,
    "weightedaveragenumberofsharesoutstandingbasic": 64227676,
    "weightedaveragenumberofdilutedsharesoutstanding": 64227676,
    "sharesoutstanding": 68389425,
    "stockissuedduringperiodvaluenewissues": 28000,
    "stockissuedduringperiodsharesnewissues": 2795700,
    "stockissuedduringperiodvaluesuccesspaymentliability": 4000,
    "stockissuedduringperiodsharessuccesspaymentliability": 349650,
    "stockissuedduringperiodvalueacquisitions": 10000,
    "stockissuedduringperiodsharesacquisitions": 1087153,
    "stockissuedduringperiodvaluevestingofrestrictedcommonstock": 10000,
    "stockissuedduringperiodsharesvestingofrestrictedcommonstock": 1020887,
    "stockissuedduringperiodvaluestockoptionsexercised": 10000,
    "stockissuedduringperiodsharesstockoptionsexercised": 974662,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 43570000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": -41000,
    "stockissuancecosts": 8000000,
    "profitloss": -370638000,
    "depreciationdepletionandamortization": 7451000,
    "investmentincomenetamortizationofdiscountandpremium": 75000,
    "researchanddevelopmentinprocess": 154953000,
    "sharebasedcompensation": 43570000,
    "changeinoperatingleaserightofuseassets": 8990000,
    "changeinfairvalueofderivativeliabilities": 1000000,
    "othernoncashincomeexpense": -63000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -746000,
    "increasedecreaseinothernoncurrentassets": 197000,
    "increasedecreaseinaccountspayable": 818000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 43914000,
    "increasedecreaseinoperatingleaseliability": 16028000,
    "increasedecreaseincollaborationreceivable": 300000000,
    "increasedecreaseincontractwithcustomerliability": 348156000,
    "increasedecreaseinothernoncurrentliabilities": 1789000,
    "netcashprovidedbyusedinoperatingactivities": -66268000,
    "paymentstoacquirepropertyplantandequipment": 46811000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 777223000,
    "proceedsfrommaturitiesprepaymentsandcallsofavailableforsalesecurities": 529270000,
    "cashacquiredfromacquisition": 620000,
    "netcashprovidedbyusedininvestingactivities": -294144000,
    "proceedsfromissuanceofcommonstock": 757449000,
    "paymentsofstockissuancecosts": 8816000,
    "financeleaseprincipalpayments": 2118000,
    "proceedsfromstockoptionsexercised": 9626000,
    "netcashprovidedbyusedinfinancingactivities": 756141000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 395729000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 572740000,
    "interestpaidnet": 567000,
    "capitalexpendituresincurredbutnotyetpaid": 9264000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 25925000,
    "equityissuancecostsinaccountspayableandaccruedexpenses": 5000,
    "fairvalueofcommonstockissuedtosettlesuccesspaymentliability": 30000000,
    "noncashorpartnoncashacquisitionvalueofliabilitiesassumed1": 36513000,
    "fairvalueofequityinstrumentsissuedinconnectionwithassetacquisition": 120032000,
    "stocksoldduringperiodsharesnewissues": 2908009,
    "sharesissuedpricepershare": 103.16,
    "grossproceedsfromissuanceofcommonstock": 300000000,
    "cashcashequivalentsandshortterminvestments": 965600000,
    "businesscombinationcontingentconsiderationarrangementsdescription": "In addition, Guide’s former stockholders and optionholders are eligible to receive up to an additional $100.0 million in technology milestone payments and $220.0 million in product milestone payments, payable in the Company’s common stock.",
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentestimatedusefullives": "Shorter of useful life or remaining term",
    "propertyplantandequipmentgross": 29905000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 16081000,
    "depreciation": 7201000,
    "cashandcashequivalentsfairvaluedisclosure": 540094000,
    "availableforsalesecuritiesdebtsecurities": 368743000,
    "equitysecuritiesfvni": 20167000,
    "assetsfairvaluedisclosure": 965647000,
    "derivativefairvalueofderivativeliability": 21000000,
    "businesscombinationcontingentconsiderationliability": 24359000,
    "liabilitiesfairvaluedisclosure": 73567000,
    "numberofsharespurchasedunderequitymethod": 546970,
    "derivativeliabilitymeasurementinput": 79.69,
    "derivativetermofcontract": "P0Y1M6D",
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 21000000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitysettlements": 15000000,
    "liabilitiesfairvalueadjustment": 500000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityperiodincreasedecrease": -5044000,
    "businesscombinationcontingentconsiderationliabilitymeasurementinput": 7.5,
    "businesscombinationcontingentconsiderationliabilityexpectedachievementyear": 2022,
    "availableforsaledebtsecuritiesamortizedcostbasis": 368778000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 32000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 67000,
    "equitysecuritiesfvnicost": 20167000,
    "availableforsaledebtsecuritiesandequitysecuritiesfvniamortizedcostbasis": 405703000,
    "availableforsaledebtsecuritiesandequitysecuritiesfvniaccumulatedgrossunrealizedgainbeforetaxes": 32000,
    "availableforsaledebtsecuritiesandequitysecuritiesfvniaccumulatedgrossunrealizedlossbeforetaxes": 82000,
    "availableforsaledebtsecuritiesandequitysecuritiesfvni": 405653000,
    "debtsecuritiesavailableforsalematurityperiod": "less than one year",
    "employeerelatedliabilitiescurrent": 11661000,
    "accruedprocessdevelopmentandmanufacturingcosts": 3833000,
    "accruedprofessionalfeescurrent": 3330000,
    "accruedresearchcosts": 3133000,
    "otheraccruedliabilitiescurrent": 6964000,
    "operatingleaseliability": 142350000,
    "securitydeposit": 9700000,
    "lesseeoperatingleasedescription": "The lease has a term of 15 years following the commencement date and provides the Company the option to extend the lease term for two five-year terms. It is subject to fixed rate escalation increases and also provides up to $20.0 million for reimbursement of tenant improvements. As the lease had not commenced as of December 31, 2021, the Company has not recorded an operating lease ROU asset or lease liability for this lease in the consolidated balance sheets.",
    "lesseeoperatingleaseleasenotyetcommencedanticipatedundiscountedleasepaymentsdue": 2600000,
    "operatingleasecost": 18309000,
    "variableleasecost": 2065000,
    "shorttermleasecost": 1145000,
    "subleaseincome": 110000,
    "leasecost": 21409000,
    "operatingleaseweightedaverageremainingleaseterm1": "P11Y1M6D",
    "operatingleaseweightedaveragediscountratepercent": 0.07,
    "operatingleasepayments": 11462000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 17059000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 17733000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 18269000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 18703000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 17143000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 115692000,
    "lesseeoperatingleaseliabilitypaymentsdue": 204599000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 62249000,
    "financeleaseliabilitypaymentsduenexttwelvemonths": 2663000,
    "financeleaseliabilitypaymentsdueyeartwo": 2013000,
    "financeleaseliabilitypaymentsdueyearthree": 511000,
    "financeleaseliabilitypaymentsdue": 5187000,
    "financeleaseliabilityundiscountedexcessamount": 568000,
    "directfinancingleaseresidualvalueofleasedasset": 675000,
    "financeleaseliability": 5294000,
    "financeleaseliabilitypaymentsinterestpercentage": 0.0876,
    "financeleaseinterestexpense": 567000,
    "nonroyaltysublicensefeesowed": 33700000,
    "successpayments": 5000000,
    "successpaymentsvaluationmultiples": 5,
    "aggregatemilestoneamount": 75900000,
    "milestoneexpense": 100000,
    "collaborationarrangementinitialterm": "P5Y",
    "potentialconsideration": 1350000000,
    "netprofitsanddevelopmentandcommercializationcostspercentage": 0.65,
    "nonrefundableupfrontpaymentreceivable": 300000000,
    "collaborationagreementperformanceobligationrevenuerecognized": 50000000,
    "collaborationagreementaggregatetransactionprice": 300000000,
    "developmentregulatoryandcommercialmilestonesreceivable": 350000000,
    "contractwithcustomerliability": 300000000,
    "collaborativearrangementrightsandobligations": "The Company had an obligation to issue $5.0 million in shares of its common stock to Prime Medicine, and Prime Medicine had an obligation to issue 5,000,000 shares of its common stock to the Company, should the Company elect to extend the collaboration beyond one year",
    "collaborationarrangementextensionterm": "P2Y",
    "stockholdersequityreversestocksplit": "one-for-9.2592",
    "commonstockvotingrights": "The holders of the Company’s common stock are entitled to one vote for each share of common stock.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P2Y",
    "commonstockcapitalsharesreservedforfutureissuance": 8792459,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1823887,
    "sharebasedcompensationarrangementbysharebasedpaymentawardannualincreasepercentage": 0.04,
    "allocatedsharebasedcompensationexpense": 26644000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 58.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 85100000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 9.88,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 104800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 6400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 73200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.714,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.767,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0111,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y1M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6034192,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1790476,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 118063,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2305895,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 32.4,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 88.15,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 37.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 11.44,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 300560000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 157633000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1126206,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 885680,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 1020887,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 13925,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 74.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 87.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 6.44,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 85.31,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1126206,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.051,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.026,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.007,
    "effectiveincometaxratereconciliationinprocessresearchanddevelopmentacquisition": -0.088,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.206,
    "deferredtaxassetsoperatinglosscarryforwards": 103868000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 23745000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 2810000,
    "deferredtaxassetsderivativeinstruments": 11483000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 5489000,
    "deferredtaxassetsamortization": 20754000,
    "deferredtaxassetsleasingarrangements": 38734000,
    "deferredtaxassetsgross": 206883000,
    "deferredtaxliabilitiesleasingarrangements": 27950000,
    "deferredtaxliabilitiespropertyplantandequipment": 1868000,
    "deferredtaxliabilitiesother": 4954000,
    "deferredtaxassetsvaluationallowance": 172111000,
    "valuationallowancedeferredtaxassetchangeinamount": 77100000,
    "operatinglosscarryforwards": 386000000,
    "netoperatinglosscarryforwardsexpirationstartingyear": 2037,
    "operatinglosscarryforwardnotsubjecttoexpiration": 382600000,
    "incometaxcreditsandadjustments": 17100000,
    "taxcreditsexpirationstartingyear": 2038,
    "opentaxyear": 2017,
    "relatedpartytransactionamountsoftransaction": -500000,
    "numberoffoundershareholders": 3,
    "relatedpartytransactionpurchasesfromrelatedparty": 200000,
    "relatedpartytransactionotherrevenuesfromtransactionswithrelatedparty": 100000,
    "definedcontributionplanname": "401(k)",
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.5,
    "definedcontributionplanemployermatchingcontributionpercent": 0.06,
    "definedcontributionplanemployerdiscretionarycontributionamount": 1100000
  },
  {
    "date": "2020-12-30",
    "symbol": "BEAM",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "BEAM",
    "entityregistrantname": "Beam Therapeutics Inc.",
    "entitycentralindexkey": 1745999,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "icfrauditorattestationflag": "false",
    "entityextransitionperiod": "false",
    "entitysmallbusiness": "false",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityshellcompany": "false",
    "security12btitle": "Common Stock, par value $0.01 per share",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-39208",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "81-5238376",
    "entityaddressaddressline1": "26 Landsdowne Street",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 857,
    "localphonenumber": "327-8775",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 162171000,
    "heldtomaturitysecuritiescurrent": 5033000,
    "prepaidexpenseandotherassetscurrent": 8650000,
    "assetscurrent": 308321000,
    "propertyplantandequipmentnet": 38513000,
    "restrictedcashnoncurrent": 14840000,
    "operatingleaserightofuseasset": 86859000,
    "otherassetsnoncurrent": 3144000,
    "assets": 451677000,
    "accountspayablecurrent": 6314000,
    "accruedexpensesandothercurrentliabilities": 18487000,
    "derivativeliabilitiescurrent": 71200000,
    "operatingleaseliabilitycurrent": 4218000,
    "financeleaseliabilitycurrent": 2118000,
    "liabilitiescurrent": 102337000,
    "operatingleaseliabilitynoncurrent": 96014000,
    "financeleaseliabilitynoncurrent": 5294000,
    "otherliabilitiesnoncurrent": 2471000,
    "liabilities": 206116000,
    "commonstockvalue": 573000,
    "additionalpaidincapital": 642633000,
    "accumulatedothercomprehensiveincomelossnetoftax": -9000,
    "retainedearningsaccumulateddeficit": -397636000,
    "stockholdersequity": -397636000,
    "liabilitiesandstockholdersequity": 451677000,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": 25000000,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 250000000,
    "commonstocksharesissued": 58446016,
    "commonstocksharesoutstanding": 57254178,
    "revenues": 24000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseMember",
    "researchanddevelopmentexpense": 103179000,
    "generalandadministrativeexpense": 29605000,
    "operatingexpenses": 132784000,
    "operatingincomeloss": -132760000,
    "derivativegainlossonderivativenet": 31800000,
    "interestandotherincomeexpensenet": 1568000,
    "otheroperatingincomeexpensenet": -61832000,
    "netincomeloss": -194592000,
    "availableforsalesecuritiestransferredsecurityunrealizedgainloss": 500000,
    "comprehensiveincomenetoftax": -194617000,
    "temporaryequityaccretiontoredemptionvalueadjustment": 1277000,
    "netincomelossavailabletocommonstockholdersbasic": -195869000,
    "earningspersharebasicanddiluted": -4.19,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 46733221,
    "sharesoutstanding": 57254178,
    "temporaryequityaccretiontoredemptionvalue": 1277000,
    "accretionofredeemableconvertiblepreferredstocktoredemptionvalue": 1277000,
    "temporaryequityconversionofredeemableconvertiblepreferredstocktocommonstockuponclosingofinitialpublicofferingvalue": -303326000,
    "temporaryequityconversionofredeemableconvertiblepreferredstocktocommonstockuponclosingofinitialpublicofferingshares": -130616784,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 303326000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 29127523,
    "stockissuedduringperiodvaluenewissues": 126624000,
    "stockissuedduringperiodsharesnewissues": 101363,
    "stockissuedduringperiodvaluevestingofrestrictedcommonstock": -16000,
    "stockissuedduringperiodsharesvestingofrestrictedcommonstock": 1638968,
    "stockissuedduringperiodvaluestockoptionsexercised": 3155000,
    "stockissuedduringperiodsharesstockoptionsexercised": 859724,
    "issuanceofcommonstockvaluerelatedtolicenseagreement": 5751000,
    "issuanceofcommonstocksharesrelatedtolicenseagreement": 375307,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationandexerciseofstockoptions": 15380000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": -25000,
    "initialpublicofferingnetofissuancecosts": 8500000,
    "profitloss": -194592000,
    "depreciation": 4735000,
    "investmentincomenetamortizationofdiscountandpremium": -118000,
    "sharebasedcompensation": 15380000,
    "changeinoperatingleaserightofuseassets": 4737000,
    "noncashresearchanddevelopmentlicenseexpense": 5651000,
    "changeinfairvalueofderivativeliabilities": 63400000,
    "othernoncashincomeexpense": 517000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 5726000,
    "increasedecreaseinothernoncurrentassets": 154000,
    "increasedecreaseinaccountspayable": 60000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 7035000,
    "increasedecreaseinoperatingleaseliabilities": 3151000,
    "increasedecreaseinothernoncurrentliabilities": 981000,
    "netcashprovidedbyusedinoperatingactivities": -95741000,
    "paymentstoacquirepropertyplantandequipment": 16357000,
    "paymentstoacquireheldtomaturitysecurities": 281612000,
    "proceedsfromsaleandmaturityofheldtomaturitysecurities": 198596000,
    "paymentstoacquirelongterminvestments": 750000,
    "netcashprovidedbyusedininvestingactivities": -100123000,
    "proceedsfromissuanceinitialpublicoffering": 127018000,
    "paymentsofstockissuancecosts": 2059000,
    "proceedsfromequipmentfinancings": 3267000,
    "repaymentofequipmentfinancings": 1569000,
    "proceedsfromstockoptionsexercised": 3155000,
    "netcashprovidedbyusedinfinancingactivities": 322322000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 126458000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 177011000,
    "incometaxespaidnet": 561000,
    "conversionofstockamountconverted1": 303326000,
    "capitalexpendituresincurredbutnotyetpaid": 5067000,
    "receiptofcommonstockinexchangefortechnologylicense": 100000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 74723000,
    "stockissued1": 5751000,
    "stockholdersequityreversestocksplit": "one-for-4.4843",
    "cashcashequivalentsandshortterminvestments": 299700000,
    "unusualorinfrequentitemnatureofeventortransaction": "The Company established new protocols to better allow its full laboratory staff access to the Company’s facilities. These protocols included several shifts working over a seven-day-week protocol.",
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentestimatedusefullives": "Shorter of useful life or remaining term",
    "propertyplantandequipmentgross": 47412000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 8899000,
    "equitysecuritiesfvni": 2600000,
    "cashandcashequivalentsfairvaluedisclosure": 12308000,
    "heldtomaturitysecuritiesfairvalue": 5033000,
    "assetsfairvaluedisclosure": 210305000,
    "derivativefairvalueofderivativeliability": 35700000,
    "liabilitiesfairvaluedisclosure": 71200000,
    "derivativeliabilitymeasurementinput": 74,
    "derivativetermofcontract": "P9Y4M9D",
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasissuccesspaymentliabilityvalue": 35700000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasissuccesspaymentliabilityperiodincreasedecrease": 31800000,
    "heldtomaturitysecurities": 137509000,
    "heldtomaturitysecuritiesaccumulatedunrecognizedholdinggain": 13000,
    "heldtomaturitysecuritiesaccumulatedunrecognizedholdingloss": 22000,
    "heldtomaturitysecuritiesinunrealizedlosspositionsqualitativedisclosurenumberofpositions": 21,
    "heldtomaturitysecuritiescontinuousunrealizedlosspositionlessthantwelvemonthsfairvalue": 82800000,
    "employeerelatedliabilitiescurrent": 7591000,
    "accruedprocessdevelopmentandmanufacturingcosts": 2272000,
    "accruedotherresearchcosts": 2423000,
    "accruedprofessionalfeescurrent": 1948000,
    "otheraccruedexpensesandothercurrentliabilities": 4253000,
    "lesseeoperatingleaseoptiontoextend": "The amended lease is subject to fixed-rate rent escalations and provides an option to extend the lease for two additional two-year periods through December 31, 2029, which were not reasonably certain of exercise.",
    "operatingleaseliability": 100232000,
    "lesseeoperatingleaseleasenotyetcommenceddescription": "Rent payments for the first phase expected to commence at the earliest in late 2021 and the rent payments for the second phase expected to commence at the earliest in the first half of 2022.",
    "lesseeoperatingleaseleasenotyetcommencedexistenceofoptiontoterminate": "true",
    "lesseeoperatingleaseleasenotyetcommencedexpirationterm": "P12Y",
    "lesseeoperatingleaseleasenotyetcommencedtenantimprovement": 23400000,
    "lesseeoperatingleaseleasenotyetcommencedexistenceofoptiontoextend": "true",
    "lesseeoperatingleaseleasenotyetcommencedoptiontoextend": "Option to extend the lease for two terms of five years each, which were not reasonably certain of exercise.",
    "lesseeoperatingleaseleasenotyetcommencedsecuritydeposit": 11800000,
    "lesseeoperatingleaseleasenotyetcommencedanticipatedundiscountedleasepaymentsdue": 42700000,
    "lesseefinanceleasetermofcontract1": "P4Y",
    "financeleaseadditionalequipmentsoldamount": 1600000,
    "operatingleasecost": 8415000,
    "variableleasecost": 929000,
    "leasecost": 9344000,
    "operatingleaseweightedaverageremainingleaseterm1": "P11Y6M",
    "operatingleaseweightedaveragediscountratepercent": 0.074,
    "operatingleasepayments": 6911000,
    "operatingleaseliabilitiesarisingfromobtainingrightofuseassets": 74723000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 9096000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 13686000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 14088000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 14519000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 14893000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 103062000,
    "lesseeoperatingleaseliabilitypaymentsdue": 169344000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 69112000,
    "financeleaseliabilitypaymentsduenexttwelvemonths": 2685000,
    "financeleaseliabilitypaymentsdueyeartwo": 2663000,
    "financeleaseliabilitypaymentsdueyearthree": 2013000,
    "financeleaseliabilitypaymentsdueyearfour": 511000,
    "financeleaseliabilitypaymentsdue": 7872000,
    "financeleaseliabilityundiscountedexcessamount": 1135000,
    "financeleaseliabilityresidualvalues": 675000,
    "financeleaseliability": 7412000,
    "financeleaseliabilitypaymentsinterestpercentage": 0.0876,
    "financeleaseprincipalpayments": 1569000,
    "financeleaseinterestexpense": 561000,
    "successpayments": 105000000,
    "successpaymentsvaluationmultiples": 40,
    "collaborativearrangementnatureandpurpose": "Company is required to reimburse Editas for certain payments Editas may be obligated to make under existing Editas license agreements related to the intellectual property being licensed to the Company, including (i) development, regulatory and commercial milestone payments and certain sublicense income payments due as a result of the Editas License Agreement and (ii) a percentage of the annual maintenance fees and patent fees due to certain of the Editas’ licensors",
    "firstsuccesspaymentmeasurementperiod": "2021-05",
    "obligatedtopayforproductdevelopmentandregulatoryapprovalmilestonespayment": 75900000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 5500000,
    "deferredrevenuerevenuerecognized1": 400000,
    "commonstocknumberofvotespershare": 1,
    "commonstockvotingrights": "The holders of common stock are entitled to one vote for each share of common stock.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "commonstockcapitalsharesreservedforfutureissuance": 7456317,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 2036376,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "The Share Pool will automatically increase on January 1st of each year from 2021 to 2029 by the lesser of (i) four percent of the number of shares of the Company’s common stock outstanding as of the close of business on the immediately preceding December 31st and (ii) the number of shares determined by the Company’s board of directors on or prior to such date for such year.",
    "allocatedsharebasedcompensationexpense": 15380000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 15.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 29900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 29300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P10M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 258500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 6900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 13800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.756,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.826,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0107,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y2M26D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5336441,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1487096,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 81978,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1432552,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9.7,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 22.47,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3.67,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 7.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 383901000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 110678000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1275338,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 1638968,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 10.95,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 52.29,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 4.24,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 6611779,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.072,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.021,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.008,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.311,
    "deferredtaxassetsoperatinglosscarryforwards": 58338000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 8756000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilitiesandother": 1445000,
    "deferredtaxassetsderivativeinstruments": 19421000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1975000,
    "deferredtaxassetsamortization": 2079000,
    "deferredtaxassetsleasingarrangements": 27340000,
    "deferredtaxassetsgross": 119354000,
    "deferredtaxliabilitiesleasingarrangements": 23692000,
    "deferredtaxliabilitiespropertyplantandequipment": 558000,
    "deferredtaxliabilitiesother": 141000,
    "deferredtaxassetsvaluationallowance": 94963000,
    "valuationallowancedeferredtaxassetchangeinamount": 58500000,
    "operatinglosscarryforwards": 208000000,
    "federalandstatenetoperatinglosscarryforwardsexpirationstartperiod": 2037,
    "operatinglosscarryforwardnotsubjecttoexpiration": 211900000,
    "incometaxcreditsandadjustments": 2000000,
    "taxcreditsexpirationstartingyear": 2033,
    "relatedpartytransactionamountsoftransaction": 500000,
    "numberoffoundershareholders": 3,
    "relatedpartytransactionpurchasesfromrelatedparty": 400000,
    "equitysecuritiesfvniunrealizedgainloss": 500000,
    "relatedpartytransactionotherrevenuesfromtransactionswithrelatedparty": 100000,
    "definedcontributionplanname": "401(k)",
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.5,
    "definedcontributionplanemployermatchingcontributionpercent": 0.06,
    "definedcontributionplanemployerdiscretionarycontributionamount": 600000,
    "mergeragreementdescription": "The Company paid Guide’s former stockholders and optionholders upfront consideration in an aggregate amount of $120.0 million, excluding customary purchase price adjustments, in shares of the Company’s common stock, based upon the volume-weighted average price of the Company’s common stock over the ten trading day period ending on February 19, 2021.",
    "revenuerecognitionmilestonemethoddescription": "In addition, Guide’s former stockholders and optionholders will be eligible to receive up to an additional $100.0 million in technology and $220.0 million in product success milestone payments, payable in the Company’s common stock valued using the volume-weighted average price of the Company’s common stock over the ten trading day period ending two trading days prior to the date on which the applicable milestone is achieved."
  }
]